New hope for sinus sufferers: drug shows promise in reducing symptoms
NCT ID NCT04362501
First seen Nov 03, 2025 · Last updated Apr 25, 2026 · Updated 19 times
Summary
This study tested whether dupilumab, an injectable drug, can improve symptoms and quality of life in adults with chronic sinusitis who do not have nasal polyps. Thirty-three participants received either dupilumab or a placebo for six months. The main goal was to see if the drug reduced symptom scores on a standard sinusitis questionnaire. The study also looked at smell, quality of life, and need for rescue medications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC SINUSITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Johns Hopkins University School of Medicine
Baltimore, Maryland, 21224, United States
Conditions
Explore the condition pages connected to this study.